BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6191410)

  • 1. Prolonged reduction in serum angiotensin converting enzyme activity after treatment of rabbits with bleomycin.
    Lazo JS; Catravas JD; Dobuler KJ; Gillis CN
    Toxicol Appl Pharmacol; 1983 Jun; 69(2):276-82. PubMed ID: 6191410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary endothelial dysfunction in the presence or absence of interstitial injury induced by intratracheally injected bleomycin in rabbits.
    Catravas JD; Lazo JS; Dobuler KJ; Mills LR; Gillis CN
    Am Rev Respir Dis; 1983 Oct; 128(4):740-6. PubMed ID: 6194726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleomycin inhibition of angiotensin-converting enzyme activity from serum, lungs, and cultured pulmonary artery endothelial cells.
    Lazo JS; Lynch TJ; McCallister J
    Am Rev Respir Dis; 1986 Jul; 134(1):73-8. PubMed ID: 2425674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of oxygen-induced lung injury in conscious rabbits. Reduced in vivo activity of angiotensin converting enzyme and removal of 5-hydroxytryptamine.
    Dobuler KJ; Catravas JD; Gillis CN
    Am Rev Respir Dis; 1982 Sep; 126(3):534-9. PubMed ID: 6289709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart angiotensin-converting enzyme activity increased after intraperitoneal bleomycin administration in rat.
    Ziai SA; Salehian P; Mahmoudian M
    Exp Lung Res; 2004 Mar; 30(2):97-104. PubMed ID: 14972770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of E. coli endotoxin on rat plasma angiotensin converting enzyme activity in vitro and in vivo.
    Deitz DM; Swartz KR; Wright M; Murphy E; Connell RS; Harrison MW
    Circ Shock; 1987; 21(1):23-9. PubMed ID: 3028670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress of bleomycin-induced lung fibrosis in rabbits.
    O'Connor CM; O'Brien A; Sweeney EC; FitzGerald MX
    Br J Exp Pathol; 1986 Aug; 67(4):461-71. PubMed ID: 2427099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of bleomycin lung toxicity using angiotensin-converting enzyme in pulmonary lavage.
    Newman RA; Kimberly PJ; Stewart JA; Kelley J
    Cancer Res; 1980 Oct; 40(10):3621-6. PubMed ID: 6159967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Possible modulatory role of nitric oxide in lung toxicity induced in rats by chronic administration of bleomycin.
    El-Khatib AS
    Chemotherapy; 2002 Dec; 48(5):244-51. PubMed ID: 12476041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical markers of bleomycin toxicity: clearance of [14C]-5-hydroxytryptamine and [3H]norepinephrine by rabbit lung in vivo.
    Catravas JD; Lazo JS; Gillis CN
    J Pharmacol Exp Ther; 1981 May; 217(2):524-9. PubMed ID: 6164780
    [No Abstract]   [Full Text] [Related]  

  • 11. Resolution of impaired pulmonary function and pulmonary hypertension after phorbol ester administration in rabbits.
    Havill AM; Riggs D; Pitt BR; Gillis CN
    Am Rev Respir Dis; 1989 Sep; 140(3):782-8. PubMed ID: 2551205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin activation protects pulmonary endothelial cells from the genotoxic effects of bleomycin.
    Hoyt DG; Rizzo M; Gerritsen ME; Pitt BR; Lazo JS
    Am J Physiol; 1997 Sep; 273(3 Pt 1):L612-7. PubMed ID: 9316496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bis-chloronitrosourea (BCNU) on pulmonary and serum angiotensin converting enzyme activity in rats.
    Smith AC; Boyd MR
    Biochem Pharmacol; 1983 Dec; 32(24):3719-22. PubMed ID: 6318769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung injury mediated by antibodies to endothelium. I. In the rabbit a repeated interaction of heterologous anti-angiotensin-converting enzyme antibodies with alveolar endothelium results in resistance to immune injury through antigenic modulation.
    Barba LM; Caldwell PR; Downie GH; Camussi G; Brentjens JR; Andres G
    J Exp Med; 1983 Dec; 158(6):2141-58. PubMed ID: 6315852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced pulmonary endothelium-bound angiotensin converting enzyme activity in diabetic rabbits.
    McCloud LL; Parkerson JB; Zou L; Rao RN; Catravas JD
    Vascul Pharmacol; 2004; 41(4-5):159-65. PubMed ID: 15607499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function analysis of angiotensin-converting enzyme inhibitors as modifiers of radiation-induced pulmonary endothelial dysfunction in rats.
    Ward WF; Molteni A; Kim YT; Ts'ao C
    Br J Radiol; 1989 Apr; 62(736):348-54. PubMed ID: 2540864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits.
    Chen X; Pitt BR; Moalli R; Gillis CN
    J Pharmacol Exp Ther; 1984 Jun; 229(3):649-53. PubMed ID: 6327968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 123I-MIBG pulmonary removal: a biochemical marker of minimal lung endothelial cell lesions.
    Slosman DO; Polla BS; Donath A
    Eur J Nucl Med; 1990; 16(8-10):633-7. PubMed ID: 1696543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary angiotensin-converting enzyme activity in the oxygen-toxic sheep.
    Howell RE; Hansen-Flaschen JH; Wheeldon EB
    Am Rev Respir Dis; 1988 Jul; 138(1):160-6. PubMed ID: 2849337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleomycin primes monocytes-macrophages for superoxide production.
    Slosman DO; Costabella PM; Roth M; Werlen G; Polla BS
    Eur Respir J; 1990 Jul; 3(7):772-8. PubMed ID: 1702065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.